|
|
Research progress on protective mechanism of Flos Carthami and Astragali Radix on cerebral ischemia injury |
WANG Kai1,2 LEI Lu2 CAO Jinyi2 DUAN Jialin2 WEN Aidong2 QIAO Yi2 YANG Zhifu2 |
1.School of Pharmacy, Shaanxi University of Chinese Medicine, Shaanxi Province, Xianyang 712046, China;
2.Department of Pharmacy, Xijing Hospital, Air Force Military Medical University, Shaanxi Province, Xi′an 710032, China |
|
|
Abstract Flos Carthami is a traditional medicine to promote blood circulation and remove blood stasis, and Astragali Radix is a traditional medicine to replenish qi, they are commonly used in treating ischemic stroke in clinic. Ischemic stroke is an acute cerebrovascular disease, also known as cerebral ischemia, with a higher mortality. After cerebral ischemia, a series of responses occur in the brain, leading to inflammation, apoptosis and brain edema. The mechanism of Flos Carthami and Astragali Radix in the treatment of ischemic stroke is mainly through antioxidant scavenging free radicals, inhibiting apoptosis and inflammatory response, and regulating some signaling pathways to play a role in brain protection. The protective mechanism of Flos Carthami and Astragali Radix is complex and has the characteristics of multiple links, multiple pathways and multiple targets. In this paper, the cerebral protective effects and mechanism of Flos Carthami and Astragali Radix in recent years are reviewed, which will provide theoretical basis for further in-depth research and clinical application.
|
|
|
|
|
[1] Mozaffarian D,Benjamin EJ,Go AS,et al. Heart disease and stroke statistics 2016 update:a report from the american heart association statistics committee and stroke statistics subcommittee [J]. Circulation,2016,133(4):e38-e360.
[2] 赵正泰,唐仕欢,马月香.补阳还五汤治疗气虚血瘀型脑卒中研究进展[J].山东中医杂志,2017,36(1):71-73.
[3] 高海珣,杨秀芬.羟基红花黄色素A药理作用研究进展[J].亚太传统医药,2015,11(19):41-44.
[4] 刘云,高晓莹,戚思华.缺血后处理脑保护作用的研究进展[J].中国脑血管病杂志,2015,12(3):160-164.
[5] 孙波,蔡鑫君,吴婷婷,等.红花提取液对小鼠缺血再灌注脑损伤保护作用的实验研究[J].中国中医药科技,2018, 25(2):205-207.
[6] 徐露,董志.注射用羟基红花黄色素A对大鼠脑神经元线粒体的保护作用研究[J].中国药房,2012,23(23):2127-2129.
[7] 陈斌,陈代梅.缺血性脑损伤机制的研究进展[J].湖北民族学院学报:医学版,2007,24(3):55-57.
[8] Ye SY,Gao WY. Hydroxysafflor yellow A protects neuron against hypoxia injury and suppresses inflammatory responses following focal ischemia reperfusion in rats [J]. Arch Pharm Res,2008,31(8):1010-1015.
[9] 向勇,朱建萍,刘丹荣.rhEPO通过调节PI3K/AKT信号通路改善大鼠脑出血后神经元损伤[J].中南医学科学杂志,2017,45(5):454-458.
[10] 谭燕萍,周福宜,梁慧超,等.羟基红花黄色素A对脑缺血再灌注损伤大鼠脑组织中PDGF含量及PI3K、Akt蛋白表达的影响[J].广东药科大学学报,2018,34(3):335-339.
[11] Yang G,Wang N,Seto SW,et al. Hydroxysafflor yellow a protects brain microvascular endothelial cells against oxygen glucose deprivation/reoxygenation injury:involvement of inhibiting autophagy via class Ⅰ PI3K/Akt/mTOR signaling pathway [J]. Brain Res Bull,2018,140:243-257.
[12] 李治华,陈曦,臧卫东,等.Wnt/β-catenin通路对大鼠脑出血的保护作用[J].郑州大学学报:医学版,2015,50(6):749-753.
[13] 付龙生,吕燕妮,徐彭.羟基红花黄色素A调控Wnt/β-catenin通路保护脑缺血小鼠血脑屏障的机制研究[J].国际中医中药杂志,2018,40(3):226-230.
[14] Singh VB,Singh MV,Piekna-Przybylska D,et al. Sonic Hedgehog mimetic prevents leukocyte infiltration into the CNS during acute HIV infection [J]. Sci Rep,2017,7(1):9578.
[15] Sun Y,Xu DP,Qin Z,et al. Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke [J]. Eur J Pharmacol,2018,818:604-609.
[16] 叶斌,李文娟,郑岚,等.红花黄色素对脑梗死血流变和血流动力学的影响[J].中华全科医学,2012,10(2):219-221.
[17] 卢岚英,李敏,谢军.黄芪甲苷对大鼠局灶性脑缺血再灌注损伤的保护作用[J].药学服务与研究,2017,17(5):392-396.
[18] 王振富,杨付明.黄芪多糖对大鼠全脑缺血再灌注损伤的保护作用[J].中国老年学杂志,2016,36(5):1059-1060.
[19] 许亮,陈春富.黄芪甲苷对大鼠脑缺血再灌注后神经元的保护作用[J].临床神经病学杂志,2011,24(3):198-201.
[20] 孙丽,王岭,李艳,等.黄芪甲苷对大鼠脑缺血再灌注损伤的保护作用和机制研究[J].中国临床神经科学,2014, 22(1):43-49.
[21] Li Y,Yang Y,Zhao Y,et al. Astragaloside Ⅳ reduces neuronal apoptosis and parthanatos in ischemic injury by preserving mitochondrial hexokinase-Ⅱ [J]. Free Rad Biol Med,2019,131:251-263.
[22] 王卫东,黄虹,邹浩元,等.缺氧缺血对体外血脑屏障通透性的影响及其机制的研究[J].实用医学杂志,2008, 24(4):515-518.
[23] Qu Y,Li Z,Zhao M,et al. Astragaloside Ⅳ attenuates cerebral ischemia-reperfusion-induced increase inpermeability of the blood-brain barrier in rats [J]. Eur J Pharmacol,2009,606(1-3):137-141.
[24] 曲友直,李敏,高国栋.黄芪注射液对大鼠脑缺血/再灌注后血脑屏障的保护作用及其机制研究[J].中国中西医结合急救杂志,2011,18(5):263-265.
[25] 曹艳华,白晓玲.兴奋性氨基酸及其受体在缺氧缺血性脑损伤中的作用[J].实用医药杂志,2005,22(3):254-255.
[26] 刘建新,王小亚,王晓峰,等.黄芪注射液对颅脑损伤后脑保护作用的实验研究[J].中国中西医结合急救杂志,2008,15(5):266-268.
[27] 许航,丁一,刘文星,等.黄芪甲苷和羟基红花黄色素A配伍抗脑缺血再灌注损伤的协同作用及机制研究[J].中华神经外科疾病研究杂志,2017,16(5):427-431.
[28] Cao J,Chen Z,Zhu Y,et al. Huangqi Honghua combination and its main componentsameliorate cerebral infarction with Qi deficiency and blood stasis syndrome by antioxidant action in rats [J]. J Ethnopharmacol,2014,155(2):1053-1060.
[29] 段晓慧,潘晓明,郭棱棱,等.黄芪注射液加红花注射液对脑缺血再灌注大鼠BDNF的影响[J].成都中医药大学学报,2009,32(1):55-57.
[30] 段晓慧,李秋云,郭棱棱,等.黄芪注射液联合红花注射液对脑缺血再灌注大鼠NT-3的影响[J].中国中医急症,2010,19(6):996-998.
[31] Rahal A,Kumar A,Singh V,et al. Oxidative stress,prooxidants,and antioxidants:the interplay [J]. Biomed Res Int,2014,2014:761264.
[32] Chen ZZ,Gong X,Guo Q,et al. Bu Yang Huan Wu Decoction prevents reperfusion injury following ischemic stroke in rats via inhibition of HIF-1α,VEGF and promotion β-ENaC expression [J]. J Ethnopharmacol,2019, 228:70-81.
[33] Chrissobolis S,Miller AA,Drummond GR,et al. Oxidative stress and endothelial dysfunction in cerebrovascular disease [J]. Front Biosci(Landmark Ed),2011,16:1733-1745. |
|
|
|